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E-mail address: vgs@fq.uniovi.es (V. Gotor).The application of three BVMOs for the enantioselective oxidation of 3-phenylbutan-2-ones with differ-
ent substituents in the aromatic moiety is described. By choosing the appropriate biocatalyst and sub-
strate combination, chiral ketones and esters can be obtained with excellent enantiopurities. This
methodology could also be applied to the resolution of racemic a-alkyl benzylketones with longer alkyl
chains as well as with two substituted a-substituted benzylacetones. A kinetic analysis revealed that the
BVMOs studied effectively convert all tested compounds showing that the enzymes are tolerant towards
the substrate structure while being highly enantioselective. These properties render BVMOs as valuable
biocatalysts for the preparation of compounds with high interest in organic synthesis.
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The use of enzymes in organic synthesis is very promising, since
these biocatalysts often show remarkable chemo-, regio- and
enantioselectivities that are difﬁcult to achieve by conventional
chemical methods. Moreover, enzyme-catalyzed processes occur
under mild and environmentally friendly conditions.1 One of the
reactions in which enzymes have shown to be an attractive choice
is the Baeyer–Villiger oxidation. This process involves the oxidative
cleavage of a carbon–carbon bond adjacent to a carbonyl group in
concert with the insertion of an oxygen atom between these two
carbons.2 The reaction can be performed using organic peroxyacids
or alkyl hydroperoxides as oxidants. Unfortunately, the employ-
ment of these compounds presents several disadvantages. To avoid
their use, different organocatalytic compounds have been tested in
Baeyer–Villiger oxidations using water or hydrogen peroxide as
oxidants.3 However, these approaches have led to catalysts that
display moderate or poor selectivities. As a result, the development
of biocatalytic methods has become highly attractive.
More than 50 years ago, it was reported for the ﬁrst time that
enzymes could catalyze the Baeyer–Villiger oxidation after which
time it took 20 years to isolate and characterize the ﬁrst Baeyer–
Villiger monooxygenase (BVMO).4 From then on, various microbial
BVMOs have been reported.5 These enzymes not only catalyze the
oxidation of carbonyl compounds, but also the oxygenation of dif-
ferent heteroatoms. BVMOs show high regio- and/or enantioselec-ll rights reserved.tivity while accepting a broad range of substrates. Oxidations
catalyzed by BVMOs are carried out in aqueous buffer at mild pH
using molecular oxygen as oxidant.
The identiﬁcation and isolation of novel BVMOs have led to an
increased interest of their synthetic potential in chemistry.6 A re-
cent example of this development is phenylacetone monooxygen-
ase (PAMO) from Thermobiﬁda fusca, a thermostable BVMO that is
able to catalyze Baeyer–Villiger reactions and other heteroatom
oxidations.7 This enzyme is the ﬁrst BVMO whose structure has
been determined, allowing a deeper understanding of this biocata-
lyst and the development of several mutagenesis studies.8 As a re-
sult, the M446G PAMO mutant has been designed which possesses
a widened substrate active site when compared with the wild-type
(wt) enzyme.9 Another BVMO studied recently is 4-hydroxyaceto-
phenone monooxygenase (HAPMO) from Pseudomonas ﬂuorescens
ACB. This protein is primarily active on aromatic compounds.10
Previously, it has been reported that both wt PAMO and HAPMO
can perform highly enantioselective resolutions of some racemic
a-alkyl benzylketones.11 Herein we report the enzymatic kinetic
resolution of a new set of aromatic ketones catalyzed by these no-
vel BVMOs with two main objectives: ﬁrstly, extending our knowl-
edge on these biocatalysts, and secondly, establishing a novel
method to prepare enantiomerically pure a-alkyl benzyl ketones
and esters by biocatalysis.
2. Results and discussion
All enzymatic Baeyer–Villiger oxidations were performed by
employing a BVMO in combination with a NADPH-regeneration
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and glucose-6-phosphate.12 By using this system only catalytic
amounts of the expensive nicotinamide coenzyme are required.
For all the substrates tested, the enzymes preferentially oxidized
the (S)-enantiomer, while the corresponding (R)-ketones remained
unaltered. The oxidation processes were performed at 20 C and
pH 8.0, in which the kinetic resolution of model substrate (±)-1a
was carried out with good conversions and high enantioselectivi-
ties using wt PAMO and HAPMO.11 When we applied M446G
PAMO as a biocatalyst, the same enantiopreference was observed,
obtaining an excellent E value as shown in Table 1 (entry 1,
E = 112)13 and a 27% conversion.
2.1. Biocatalyzed oxidation of substituted 3-phenylbutan-2-
ones
Initially, we investigated the ability of these three BVMOs to cat-
alyze the kinetic resolution of 3-phenylbutan-2-ones bearing differ-
ent substituent groups on the aromatic ring. When wt PAMO was
employed as a biocatalyst, the presence of a substituent on the aro-
matic ring generally resulted in a decreased enantioselectivity. Only
the biooxidation of 3-(3-methylphenyl)butan-2-one (±)-4a
occurred with an excellent E value (E = 119) leading to a 30% of (S)-
4b after 1 h. Good enantioselectivities were obtained in the resolu-
tion of the methoxyphenylbutan-2-ones (±)-2a (E = 32) and (±)-5a
(E = 46), thereby noting that the reaction occurred faster for the 4-
methoxy derivative than for the 3-methoxy case. The oxidation of
3-(3-chlorophenyl)butan-2-one (±)-8a yielded (R)-8a and (S)-8b
with a good E value, as well as the wt PAMO biocatalyzed resolution
of 3-(4-nitrophenyl)butan-2-one (±)-10a (E = 40). The oxidations of
the remaining ketones testedwere carried out with poor enantiose-
lectivities (E <20). Wt PAMO presented a similar activity for all the
substrates, conversions being obtained between 19% and 33% after
1 h, except for the ketones bearing strong electron-withdrawing
groups. The oxidation of these compounds, (±)-9a and (±)-10a,was
performed with high conversions (c  50% after 30 min).
M446G PAMO seemed to prefer the presence of electron-with-
drawing groups in the aromatic moiety in terms of activity, as
shown in Table 1 for substrates (±)-8a, (±)-9a and (±)-10a. This en-
zyme catalyzed the resolution of the derivatives (±)-4a and (±)-10a
with excellent enantioselectivties. The oxidation was very slowTable 1
Baeyer–Villiger monooxygenases-biocatalyzed oxidation of racemic ketones (±)-1–10a in
O
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Ketone X Wt PAMO
t (h) eeSb (%) eepb (%) cc (%) Ed eeSb (%)
1a H 1 36 98 27 188 36
2a 4-OMe 1 44 91 33 32 9
3a 4-Et 1 36 86 30 19 29
4a 3-Me 1 42 97 30 119 10
5a 3-OMe 1 22 95 19 46 11
6a 4-Br 1 17 48 26 3 11
7a 4-Cl 1 39 82 32 15 11
8a 3-Cl 1 27 92 22 33 38
9a 3-CF3 0.5 47 43 52 5 39
10a 4-NO2 0.5 87 87 50 40 98
a For reaction conditions see Section 4.
b Enantiomeric excesses (ee) determined by GC, except (±)-10b, for which HPLC was
c Conversion determined by GC.
d Enantiomeric ratio, E = ln{(1  ees)/[1 + (ees/eep)]}/ln{(1 + ees)/[1 + (ees/eep)]}.when resolving (±)-4a (9% of (S)-4b after 1 h), while for (±)-10a a
50% of (S)-10b was reached after only 30 min. Biocatalyzed resolu-
tion of the methoxy derivatives (±)-2a and (±)-5a, as well as the
biooxidation of the para-halogenated ketones (±)-6a and (±)-7a,
led to the (R)-ketones and (S)-esters with good E values. The pres-
ence of the 4-ethyl-, 3-chloro- or 3-triﬂuoromethyl substituents in
the aromatic ring had a negative effect on the selectivity of M446G
PAMO (Table 1).
Furthermore, HAPMO was explored as biocatalyst in the selec-
tive oxidation of substituted racemic benzylketones. As for the
two PAMO enzymes, this BVMO was found to be able to catalyze
the resolution of 3-(3-methylphenyl)butan-2-one to obtain (R)-4a
and (S)-4b with high enantioselectivity (E = 126) and 20% conver-
sion after 2 h. HAPMO catalyzed the formation of (S)-1-(3-triﬂuo-
romethylphenyl)ethyl acetate (S)-9b with high E value and 39%
conversion after 1 h, in contrast to the low selectivity showed by
wt PAMO and M446G for this ketone. The 3- and 4-chlorophenylb-
utan-2-ones (±)-7a and (±)-8awere also converted by HAPMOwith
good enantioselectivities, especially when oxidizing the 4-chloro
derivative (E = 50 and 43% conversion after 2 h). The reaction was
much slower for (±)-8a (12% of (S)-8b after 2 h). The HAPMO-cata-
lyzed oxidation of (±)-2a occurred with good enantioselectivity
(E = 41), resulting in 14% of (S)-2b after 2 h. As shown in entry
3,3-(4-ethylphenyl)butan-2-one (±)-3a seemed not to be a good
substrate for the all BVMOs studied. HAPMO oxidized with moder-
ate/poor selectivities ketone (±)-5a (in contrast to the results re-
ported for both PAMO biocatalysts), as well as the 4-bromo- and
4-nitroderivatives (±)-6a and (±)-10a.
2.2. Oxidation of long alkyl chain ketones catalyzed by BVMOs
In addition to the oxidation of substituted 3-phenylbutan-2-
ones, we investigated the ability of the BVMOs to catalyze the oxi-
dation of racemic benzylketones which contain longer alkyl chains
on either R1, R2 or both, as shown in Table 2. Regardless of which
BVMO was employed, all the ketones with longer alkyl chains led
to lower conversions when compared to the biooxidation of (±)-
1a. The biocatalyzed oxidation of racemic 3-phenylheptan-2-one
(±)-11a and (±)-3-phenylhex-5-en-2-one (±)-12a yielded to the
corresponding (R)-ketones and (S)-esters with low or moderate









eepb (%) cc (%) Ed t (h) eeSb (%) eepb (%) cc (%) Ed
97 27 112 2 33 98 25 136
97 8 61 2 16 95 14 41
86 25 18 2 66 68 49 10
98 9 109 2 25 98 20 126
96 11 52 2 71 76 48 15
95 11 44 2 8 25 42 2
96 10 54 2 70 92 43 50
73 34 9 2 13 96 12 63
92 30 36 1 62 97 39 112
93 50 121 1 53 58 48 6
used.
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11a: R1: Butyl R2: Methyl
12a: R1: Allyl R2: Methyl
13a: R1: Propyl R2: Ethyl
14a: R1: Butyl R2: Ethyl
15a: R1: Allyl R2: Ethyl
16a: R1: Methyl R2: Butyl
Ketone Wt PAMO M446G PAMO HAPMO
t (h) eeS (%) eep (%) c (%) E t (h) eeS (%) eep (%) c (%) E t (h) eeS (%) eep (%) c (%) E
11a 2 3 28 10 2 4 9 86 9 15 4 n.d. n.d. 63 n.d.
12a 2 26 64 29 6 4 n.d. n.d. 63 n.d. 4 n.d. n.d. 63 n.d.
13a 2 13 55 19 4 4 5 98 5 103 4 29 96 23 66
14a 2 10 86 10 15 4 10 95 9 43 4 n.d. n.d. 63 n.d.
15a 2 38 77 33 11 4 8 96 8 53 4 5 98 5 104
16a 2 n.d. n.d. 63 n.d. 4 n.d. n.d. 63 n.d. 4 n.d. n.d. 63 n.d.
17a 4 8 10 43 1 24 n.d. n.d. 63 n.d. 24 n.d. n.d. 63 n.d.
18a 4 32 95 25 52 24 n.d. n.d. 63 n.d. 24 6 97 6 69
n.d.: not determined.
a For reaction conditions see Experimental. For compounds (±)-11–15a, E and ees were calculated from eep and c values. E = ln[1  c(1 + eep)]/ln[1  c(1  eep)]. Enan-
tiomeric excesses (±)-18a–b were determined by GC. In case of (±)-17, enantiomeric ratio was calculated from ees and c. E = ln[(1  c)(1  ees)]/ln[(1  c)(1 + ees)].
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catalysts, with HAPMO being the enzyme most suited for the ki-
netic resolution (E = 66 and 23% conversion after 2 h). The
oxidation catalyzed by M446G PAMO led to (R)-13a and (S)-13b
with high selectivity but a low conversion after 4 h, while a very
low E value was obtained when wt PAMO was employed. Mutant
M446G was able to catalyze the selective oxidation of 4-phenyloc-
tan-3-one (±)-14a (E = 43). Unfortunately, only 9% of (S)-14b was
obtained after 4 h. Wt PAMO and HAPMO were found to be unsuit-
able biocatalysts for the kinetic resolution of this ketone. HAPMO
and M446G PAMO were able to oxidize selectively racemic 4-phe-
nylhept-6-en-3-one (±)-15a, but with very low conversions. On the
other hand, wt PAMO converted 33% of this ketone, although with
poor selectivity. Racemic 2-phenylheptan-3-one (±)-16a was also
subjected to enzymatic oxidation by the BVMOs, but no formation
of (S)-16b was achieved after long times, indicating that the pres-
ence of a long group close to the carbonyl moiety is poorly ac-
cepted by these three biocatalysts. This observation is not
completely unexpected for wt PAMO, as it was previously shown
that a similar substrate (1-phenylhexan-2-one) was poorly con-
verted by this enzyme.7b
Finally, two a-alkyl benzylacetones were analyzed as BVMOs
substrates. The enzymatic oxidation of 4-phenylpentan-2-one
(±)-17a led to (S)-17b with a 43% conversion in a process without
selectivity after 4 h when employing wt-PAMO. No reaction was
observed when this compound was oxidized in the presence of
M446G PAMO or HAPMO after 1 day of reaction. In contrast, when
3-methyl-4-phenylbutan-2-one (±)-18a was subjected to enzy-
matic oxidation catalyzed by wt PAMO or HAPMO, good enantiose-
lectivities were obtained (E = 52 and 69, respectively). The reaction
was much faster with PAMO, obtaining (S)-18b in 25% conversion
after 4 h. No product formation was observed after 1 day when
M446G PAMO was employed as a biocatalyst. The low activity
showed by HAPMO and mutant M446G in the oxidation of this
type of substrate is in agreement with recent studies in which
these enzymes appeared to prefer aromatic ketones that have the
carbonyl group close to the phenyl ring, for example, phenylace-
tone or acetophenone derivatives.9,10a2.3. Kinetic parameters of BVMOs for the oxidation of racemic
ketones (±)-1–10a
In order to obtain a better insight in how the different substit-
uents of the 3-phenylbutan-2-ones affect the efﬁciency by which
these ketones are converted, we determined their steady-state
kinetic parameters (Table 3). No correlation was found between
r-parameter for the substituents (described as the Hammet rela-
tionship, which represents a contribution of factors such a reso-
nance and both ﬁeld and inductive effects) and the kinetic
behaviour. Depending on the nature and the position of the sub-
stituents, different effects on both apparent afﬁnity (KM) and cat-
alytic activity (kcat) were achieved. The catalytic activity of wt
PAMO and mutant M446G was found to be quite similar
(kcat  3 s1) for all the ketones, while HAPMO showed more vari-
ety in its kcat value (from 2.2 to 6.5 s1). This suggests that in
PAMO the rate limiting step is probably a kinetic event unrelated
to the reactivity of the substrate, which is in line with a recently
detailed kinetic study of PAMO.8c For HAPMO, the reaction may
be limited by the chemical/sterical properties of the substrate
or product.
In terms of KM, M446G PAMO displays 5–10 times lower afﬁn-
ity (higher KM) for the substrates than wt PAMO. This is in agree-
ment with previous experiments.9 Both wild-type and mutant
PAMO showed a relative high efﬁciency towards the ketones
(±)-1a, (±)-4a, (±)-8a and (±)-10a. On the contrary, substrates
(±)-3a, (±)-6a and (±)-7a were converted with a much higher
catalytic efﬁciency by HAPMO, mainly due to the high afﬁnity of
the enzyme towards these substrates. No clear correlation was
found between the catalytic efﬁciency of the enzymes and their
achieved conversion, suggesting that in some cases (enantioselec-
tive) product inhibition might occur. While the catalytic efﬁcien-
cies found for PAMO and its mutant vary by less than a factor
of 20, the kcat/KM values found for HAPMO showed a much higher
variation (over 500-fold). Such differences have been described
before for this enzyme, when substituted acetophenones were
subjected to a similar study.10b HAPMO clearly showed a low
catalytic efﬁciency towards 3-phenylbutan-2-ones with no or
Table 3
Steady-state kinetic parameters of wild-type PAMO, M446G PAMO and HAPMO for the oxidation of ketones (±)-1a–10a
Substrate Wt PAMO M446G PAMO HAPMO
KM [lM] kcat [s1] kcat/KM [103 s1 M1] KM [lM] kcat [s1] kcat/KM [103 s1 M1] KM [lM] kcat [s1] kcat/KM [103 s1 M1]
(±)-1a 16 2.9 177 168 2.7 16 457 3.2 7.1
(±)-2a 69 2.8 41 850 2.8 3.3 55 4.5 82
(±)-3a 101 2.9 29 586 2.5 4.2 7 4.7 713
(±)-4a 25 3.2 131 231 3.6 15 >3,500a >5 1.3
(±)-5a 75 3.0 41 1,000 3.1 3.1 165 2.2 13
(±)-6a 35 2.9 84 506 2.9 6 8 6.5 831
(±)-7a 34 2.9 87 196 2.7 14 26 5.6 215
(±)-8a 8 3.2 377 60 2.8 48 437 2.7 6.2
(±)-9a 93 3.4 36 543 2.7 4.9 230 2.2 9.5
(±)-10a 40 4.5 113 180 2.2 12 40 3.5 87.5
a Due to limited solubility of compound (±)-4a, the substrate concentration could not be increased beyond this value.
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substituted ketones were efﬁciently oxidized.
3. Conclusions
The enantioselective oxidation of racemic benzylketones by
wt PAMO, M446G PAMO and HAPMO enables the enantioselec-
tive synthesis of various (R)-a-alkyl-benzylketones and (S)-a-al-
kyl-benzylesters. High enantioselectivities can be achieved by
combining the right biocatalyst and substrate structure. The
three enzymes showed an excellent E value in the resolution of
3-(3-methylphenyl)butan-2-one (±)-4a, while two ketones pre-
senting electron-withdrawing groups, such as the 3-triﬂuoro-
methyl- and the 4-nitro-3-phenylbutan-2-ones, are resolved
with excellent enantioselectivities by HAPMO and M446G PAMO,
respectively. The other a-alkyl benzylketones tested can be re-
solved with good E values (EP 40) depending on the enzyme
employed, with the exception of 3-(4-ethylphenyl)butan-2-one,
which is a poor substrate for all the three enzymes. Most of
the long alkyl chain ketones are poorly accepted by the three
BVMOs. Only when M446G PAMO and HAPMO are employed
in the kinetic resolution of (±)-13 and (±)-15, respectively, good
enantioselectivites are obtained. Wt PAMO and HAPMO were also
able to oxidize 3-methyl-4-phenylbutan-2-one with good E values.
Kinetic analysis revealed that all substrates tested are converted at a
similar rate by all three biocatalysts. Differences in catalytic efﬁcien-
cies were mainly caused by varying KM values. No clear correlation
was found between the properties of the different substituents
and the enantioselectivity and/or kinetic parameters. The various
effects of the substituents on the enzymatic properties indicate that
the structural character of the 3-phenylbutan-2-ones determines
whether oxidation is efﬁcient and selective.
4. Experimental
4.1. General
Recombinant histidine-tagged PAMO,7a its mutant M446G9 and
recombinant HAPMO10a were overexpressed and puriﬁed as previ-
ously described. Glucose-6-phosphate dehydrogenase from Leuco-
nostoc mesenteroides was obtained from Fluka-Biochemika. All
reagents and solvents were of the highest quality grade available
and were obtained from Sigma–Aldrich–Fluka and Acros Organics.
Chemical reactions were monitored by analytical TLC, performed
on Merck Silica Gel 60 F254 plates and visualized by UV irradiation.
Flash chromatography was carried out with Silica Gel 60 (230–
240 mesh, Merck). IR spectra were recorded on a Perkin–Elmer
1720-X infrared Fourier transform spectrophotometer using KBr
pellets. UV spectra were performed on a Perkin–Elmer Lambda
Bio10 UV/vis Spectrophotometer. 1H NMR, 13C NMR and DEPT spec-tra were recorded with tetramethylsilane (TMS) as the internal
standard with a Bruker AC-300 DPX (1H: 300.13 MHz; 13C:
75.5 MHz) spectrometer. The chemical shift values (d) are given in
ppm. APCI+ and ESI+ using a Hewlett–Packard 1100 chromatograph
mass detector or EI+ with a Hewlett–Packard 5973 mass spectrom-
eter were used to record mass spectra (MS). GC analyses were per-
formed on a Hewlett–Packard 6890 Series II chromatograph
equipped with a Restek RtbDEXse (30 m  0.25 mm  0.25 lm,
1 bar N2), a Varian CP-Chiralsil-DEX CB (25 m  0.32 mm 
0.25 lm, 1 bar N2) or a Mercherey-Nagel Hydrodex-b-TBOAc
(30 m  0.25 mm  0.25 lm, 1 bar N2) for chiral determinations
or a HP-1 (crosslinked methyl siloxane, 30 m  0.25 mm 0.25 lm,
1.0 bar N2) from Hewlett–Packard for measuring the conversions
values. For all the analyses, the injector temperature is 225 C and
the FID temperature is 250 C. HPLC analyses were developed with
a Hewlett–Packard 1100 LC liquid chromatograph equipped with a
Chiralcel OD (0.46 cm  25 cm) or Chiralpak IA (0.46 cm  25 cm)
chiral column from Daicel.
Absolute conﬁguration of esters (S)-1–15b and ketones (R)-17–
18a was determined by (i) comparison of elution order of GC with
published data,11,14 (ii) hydrolysis of the esters to the correspond-
ing alcohols employing NaOMe in methanol, and comparison of the
elution order on HPLC with published data15 or by (iii) co-injection
with commercially available material.4.2. Synthesis of the racemic ketones (±)-1–18a and esters (±)-
1–18b
The racemic ketones (±)-1–16a were synthesized according to
the literature, using with 1-phenylpropan-2-one or 1-phenylb-
utan-2-one the corresponding alkyl or allyl iodide and NaOH in a bi-
phasic medium water/CH2Cl2.16 Ketones were obtained with yields
from25% to 90% depending on the substrate structure. Racemic ace-
tates (±)-2–5bwere synthesized by chemical Baeyer–Villiger oxida-
tion with m-CPBA/dichlorometane (yields from 60% to 90%), while
esters (±)-1b and (±)-6–18b were prepared by chemical acylation
of the racemic alcohols employing pyridine and the corresponding
anhydride in CH2Cl2 with high yields. Compounds 1a,11 2a,14b
6a,14b 7a,17a 9a,14b 10a,17b 12a,17c 1b,11 2b,14b 4b,17d 5b,17d 6b,14b
7b,14a 9b,14b 10b,14a11b,17e 12b,17f 16b,17g 17b17h and 18b17i exhibit
physical and spectral properties in accord with those reported.
4-Phenylpentan-2-one, (±)-17a and 3-methyl-4-phenylbutan-
2-one, (±)-18a were obtained according to the literature with
30–40% yield, by Heck arylation of 3-penten-2-ol or 3-methyl-3-
buten-2-ol, respectively, using iodobenzene in presence of palla-
dium chloride, tetra-n-butylammonium bromide and NaHCO3.18
3-Methyl-3-buten-2-ol was prepared by addition of methyl mag-
nesium iodide to a methacrolein solution in diethyl ether. Com-
pounds (±)-17–18a exhibit physical and spectral properties in
accord with those reported.17h,19
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Colourless oil. IR (KBr): m 3055, 2986, 1712, 1423 cm1. 1H NMR
(CDCl3, 300.13 MHz): d 0.77 (t, 3JHH = 7.3 Hz, 3 H), 1.08–1.20 (m,
2H), 1.34 (d, 3JHH = 7.0 Hz, 3 H), 1.39–1.46 (m, 2H), 2.31 (t,
3JHH = 7.3 Hz, 2H), 3.71 (q, 3JHH = 6.9 Hz, 1 H), 7.16–7.31 (m, 5H).
13C NMR (CDCl3, 75.5 MHz): d 13.7 (CH3), 17.4 (CH3), 22.1 (CH2),
25.9 (CH2), 40.7 (CH2), 52.9 (CH), 127.0 (2 CH), 127.8 (CH), 128.8
(2 CH), 140.7 (C), 211.0 (C@O). MS (EI+): m/z (%) 190 (11) [M+],
105 (81), 85 (100).
4.3. General procedure for the BVMO-catalyzed oxidation of the
racemic ketones (±)-1–18a
Unless otherwise stated, the starting racemic ketones (±)-1–18a
(20 mM) were dissolved in a 50 mM Tris/HCl buffer at pH 8.0
(1.0 mL) containing glucose-6-phosphate (40 mM), glucose-6-
phosphate dehydrogenase (5.0 units), NADPH (0.2 mM) and the
corresponding Baeyer–Villiger monooxygenase (5 lM). Reactions
are shaken at 250 rpm and 20 C in a rotatory shaker for the times
established. Once ﬁnished, the crude reactions were extracted with
AcOEt (2  500 lL). The organic phases were dried onto Na2SO4
and analyzed directly by GC or HPLC in order to determine the con-
version of the oxidations and the enantiomeric excesses of the es-
ters (S)-1–18b and the remaining ketones (R)-1–18a.
4.4. Scale up of the BVMO-catalyzed oxidation of racemic
ketones (±)-3–5a, (±)-8a, (±)-11a and (±)-13–15a
Racemic ketones (±)-3–5a, (±)-8a, (±)-11a, (±)-13–15a (20 mM)
were dissolved in a 50 mM Tris/HCl buffer at pH 8.0 (12.5 mL) con-
taining glucose-6-phosphate (40 mM), glucose-6-phosphate dehy-
drogenase (5.0 units), NADPH (0.2 mM) and the corresponding
Baeyer–Villiger monooxygenase [wt PAMO for (±)-3–4a, (±)-8a
and (±)-15a; HAPMO for (±)-5a and (±)-13a; M446G PAMO for
(±)-11a and (±)-14a (5 lM)]. Reactions are shaken at 250 rpm
and 20 C in a rotatory shaker for the times established (1 h for
(±)-3-4a and (±)-8a, 2 h for (±)-5a (±)-15a and 4 h for (±)-13–
14a). Once ﬁnished, the crude reactions were extracted with EtOAc
(4  5 mL). The organic phases were dried onto Na2SO4 ﬁltered and
evaporated under reduced pressure. The crude residues were puri-
ﬁed by ﬂash chromatography on silica gel using hexane/diethyl
ether 8:2 (compounds 3–4a), hexane/diethyl ether 7:3 (ketones
5a and 8a) or hexane/ethyl acetate 8:2 (compounds 13–15a) to af-
ford: (R)-3a (22.6 mg, 73% yield) and (S)-3b (10.4 mg, 71% yield);
(R)-4a (19.9 mg, 68% yield) and (S)-4b (10.6 mg, 79% yield); (R)-
5a (18.3 mg, 79% yield) and (S)-5b (18.0 mg, 77% yield); (R)-8a
(29.8 mg, 82% yield) and (S)-8b (8.5 mg, 78% yield); (R)-11a
(32.6 mg, 74% yield) and (S)-11b (3.7 mg, 79% yield); (R)-13a
(25.8 mg, 70% yield) and (S)-13b (10.5 mg, 87% yield); (R)-14a
(36.8 mg, 79% yield) and (S)-14b (4.4 mg, 88% yield); (R)-15a
(24.6 mg, 78% yield) and (S)-15b (12.8 mg, 76% yield).
4.4.1. (R)-3-(4-Ethylphenyl)butan-2-one, (R)-3a
Colourless oil. IR (KBr): m 3054, 2967, 1714, 1452 cm1. 1H NMR
(CDCl3, 300.13 MHz): d 1.23 (t, 3JHH = 7.5 Hz, 3 H), 1.37 (d,
3JHH = 6.9 Hz, 3H), 2.04 (s, 3H), 2.63 (q, 3JHH = 7.6 Hz, 2H), 3.71 (q,
3JHH = 6.9 Hz, 1H), 7.11–7.16 (m, 4H). 13C NMR (CDCl3, 75.5 MHz):
d 15.4 (CH3), 17.1 (CH3), 28.2 (CH3), 28.3 (CH2), 53.3 (CH), 127.7
(2 CH), 128.3 (2CH), 137.7 (C), 143.1 (C), 209.1 (C@O). MS (APCI+):
m/z (%) 177 (100) [M+H+]. ½a25D ¼ 12:8 (c 0.80, CHCl3), ee 36%.
4.4.2. (S)-1-(4-Ethylphenyl)ethyl acetate, (S)-3b
Colourless oil. IR (KBr): m 3054, 2986, 1733, 1507 cm1. 1H NMR
(CDCl3, 300.13 MHz): d 1.25 (t, 3JHH = 7.6 Hz, 3 H), 1.54 (d, 3JHH =
6.5 Hz, 3H), 2.08 (s, 3H), 2.60–2.69 (m, 2H), 5.88 (q, 3JHH = 6.5 Hz,
1H,), 7.15–7.21 (m, 2H), 7.27–7.31 (m, 2H). 13C NMR (CDCl3,75.5 MHz): d 15.4 (CH3), 21.3 (CH3), 22.0 (CH3), 72.2 (CH), 126.1
(2CH), 127.6 (2CH), 138.8 (C), 143.9 (C), 170.3 (C@O). MS (EI+): m/z
(%) 192 (20) [M+], 117 (100). ½a25D ¼ þ35:9 (c 0.74, CHCl3), ee 86%.
4.4.3. (R)-3-(3-Methylphenyl)butan-2-one, (R)-4a
Yellow pale oil. IR (KBr): m 3054, 2980, 1713, 1606, 1490 cm1.
1H NMR (CDCl3, 300.13 MHz): d 1.37 (d, 3JHH = 6.9 Hz, 3H), 2.05 (s,
3H), 2.34 (s, 3H), 3.70 (q, 3JHH = 6.9 Hz, 1H), 7.00–7.09 (m, 3H),
7.19–7.25 (m, 1H). 13C NMR (CDCl3, 75.5 MHz): d 17.1 (CH3), 21.3
(CH3), 28.3 (CH3), 53.6 (CH), 124.8 (CH), 127.8 (CH), 128.4 (CH),
128.7 (CH), 138.6 (C), 140.4 (C), 207.1 (C@O). MS (APCI+): m/z (%)
163 (100) [M+H+]. ½a25D ¼ 21:8 (c 1.18, CHCl3), ee 42%.
4.4.4. (R)-3-(3-Methoxylphenyl)butan-2-one, (R)-5a
Yellow pale oil. IR (KBr): m 3055, 2983, 1712, 1609, 1487 cm1.
1H NMR (CDCl3, 300.13 MHz): d 1.39 (d, 3JHH = 7.0 Hz, 3H), 2.06 (s,
3H), 3.72 (q, 3JHH = 7.0 Hz, 1H), 3.81 (s, 3H), 6.75–6.83 (m, 3H),
7.23–7.29 (m, 1H). 13C NMR (CDCl3, 75.5 MHz): d 17.0 (CH3), 28.2
(CH3), 53.6 (CH), 55.1 (CH3), 112.3 (CH), 113.4 (CH), 120.1 (CH),
129.8 (CH), 142.0 (C), 159.9 (C), 208.6 (C@O). MS (APCI+): m/z (%)
179 (100) [M+H+]. ½a25D ¼ 31:6 (c 1.40, CHCl3), ee 71%.
4.4.5. (R)-3-(3-Chlorophenyl)butan-2-one, (R)-8a
Colourless oil. IR (KBr): m 3054, 2985, 1714, 1422 cm1. 1H NMR
(CDCl3, 300.13 MHz): d 1.37 (d, 3JHH = 7.0 Hz, 3H), 2.05 (s, 3H), 3.71
(q, 3JHH = 7.0 Hz, 1H), 7.07–7.10 (m, 1H), 7.20–7.26 (m, 3H). 13C
NMR (CDCl3, 75.5 MHz): d 17.1 (CH3), 28.4 (CH3), 53.2 (CH),
125.9 (CH), 127.4 (CH), 128.0 (CH), 130.1 (CH), 134.7 (C), 142.4
(C), 208.0 (C@O). MS (APCI+): m/z (%) 183 (30) [M+H+].
½a25D ¼ 12:0 (c 0.98, CHCl3), ee 27%.
4.4.6. (S)-1-(3-Chlorophenyl)ethyl acetate, (S)-8b
Colourless oil. IR (KBr): m 3054, 2987, 1733, 1507 cm1. 1H NMR
(CDCl3, 300.13 MHz): d 1.44 (d, 3JHH = 6.6 Hz, 3H), 2.01 (s, 3H), 5.75
(q, 3JHH = 6.6 Hz, 1H), 7.14–7.26 (m, 4H). 13C NMR (CDCl3,
75.5 MHz): d 21.2 (CH3), 22.1 (CH3), 71.5 (CH), 124.2 (CH), 126.1
(CH), 127.9 (CH), 129.7 (CH), 134.3 (C), 143.7 (C), 170.1 (C@O).
MS (EI+): m/z (%) 198 (13) [M+], 156 (70), 138 (38). ½a25D ¼ þ67:8
(c 0.78, CHCl3), ee 92%.
4.4.7. (R)-3-Phenylheptan-2-one, (R)-11a
Yellowpale oil. IR (KBr): m 3055, 2960, 1711, 1601, 1423 cm1. 1H
NMR (CDCl3, 300.13 MHz): d 0.81 (t, 3JHH = 7.0 Hz, 3 H), 1.07–1.19
(m, 2H), 1.21–1.28 (m, 2H), 1.60–1.69 (m, 1H), 1.92–2.05 (m, 4H),
3.55 (t, 3JHH = 7.5 Hz, 1H), 7.15–7.29 (m, 5H). 13C NMR (CDCl3,
75.5 MHz): d 13.8 (CH3), 22.5 (CH2), 28.9 (CH3), 29.6 (CH2), 31.4
(CH2), 59.7 (CH), 127.1 (CH), 128.2 (2 CH), 128.8 (2 CH), 139.1 (C),
208.6 (C@O). MS (EI+):m/z (%) 190 (2) [M+] 147 (31), 91 (100).
4.4.8. (R)-4-Phenylheptan-3-one, (R)-13a
Colourless oil. IR (KBr): m 3055, 2987, 1716, 1423 cm1. 1H NMR
(CDCl3, 300.13 MHz): d 0.90 (t, 3JHH = 7.2 Hz, 3 H), 0.98 (t,
3JHH = 7.2 Hz, 3 H), 1.15–1.29 (m, 2H), 1.64–1.77 (m, 1H), 1.97–
2.10 (m, 1 H), 2.32–2.49 (m, 2H), 3.66 (t, 3JHH = 7.5 Hz, 1H), 7.22–
7.34 (m, 5H). 13C NMR (CDCl3, 75.5 MHz): d 7.8 (CH3), 13.9 (CH3),
20.6 (CH2), 34.2 (CH2), 35.0 (CH), 58.4 (CH), 126.9 (CH), 128.1 (2
CH), 128.7 (2 CH), 139.3 (C), 211.2 (C@O). MS (EI+): m/z (%) 190
(9) [M+], 105 (75), 85 (100). ½a25D ¼ 10:8 (c 1.12, CHCl3), ee 29%.
4.4.9. (S)-1-Phenylbutyl propionate, (S)-13b
Yellow pale oil. IR (KBr): m 3055, 2987, 1731, 1423 cm1. 1H
NMR (CDCl3, 300.13 MHz): d 0.85 (t, 3JHH = 7.2 Hz, 3H), 1.07 (t,
3JHH = 7.4 Hz, 3H), 1.15–1.34 (m, 2H), 1.61–1.73 (m, 1H), 1.77–
1.90 (m, 1H), 2.24–2.33 (m, 2H), 5.69 (t, 3JHH = 7.0 Hz, 1H), 7.20–
7.28 (m, 5H). 13C NMR (CDCl3, 75.5 MHz): d 9.1 (CH3), 13.7 (CH3),
18.7 (CH2), 27.8 (CH2), 38.5 (CH2), 75.6 (CH), 126.4 (2CH), 127.7
C. Rodríguez et al. / Tetrahedron: Asymmetry 20 (2009) 1168–1173 1173(CH), 128.3 (2CH), 140.9 (C), 173.7 (C@O). MS (ESI+): m/z (%) 229
(100) [M+Na+]. ½a25D ¼ þ35:8 (c 0.91, CHCl3), ee 96%.
4.4.10. (R)-4-Phenyloctan-3-one, (R)-14a
Yellow pale oil. IR (KBr): m 3055, 2987, 1719, 1662, 1423 cm1.
1H NMR (CDCl3, 300.13 MHz): d 0.89 (t, 3JHH = 7.0 Hz, 3H), 1.00 (t,
3JHH = 7.6 Hz, 3H), 1.16–1.21 (m, 2H), 1.22–1.37 (m, 2H), 1.69–
1.83 (m, 1H), 2.02–2.14 (m, 1H), 2.38–2.49 (m, 2H), 3.66 (t,
3JHH = 7.4 Hz, 1H), 7.24–7.36 (m, 5H). 13C NMR (CDCl3, 75.5 MHz):
d 13.8 (CH3), 13.8 (CH3), 22.5 (CH2), 29.7 (CH2), 31.9 (CH2), 35.0
(CH2), 58.7 (CH), 126.9 (CH), 128.2 (2 CH), 128.7 (2CH), 139.4 (C),
211.3 (C@O). MS (EI+): m/z (%) 204 (1) [M+], 148 (20), 91 (100).
4.4.11. (S)-1-Phenylpentyl propionate, (S)-14b
Yellow pale oil. IR (KBr): m 3055, 2986, 1731, 1423 cm1. 1H
NMR (CDCl3, 300.13 MHz): d 0.81 (t, 3JHH = 7.0 Hz, 3H), 1.10 (t,
3JHH = 6.6 Hz, 3H), 1.20–1.28 (m, 4H), 1.64–1.76 (m, 1H), 1.78–
1.90 (m, 1H), 2.24–2.33 (m, 2H), 5.67 (t, 3JHH = 6.3 Hz, 1H), 7.19–
7.28 (m, 5H). 13C NMR (CDCl3, 75.5 MHz): d 9.0 (CH3), 13.9 (CH3),
22.4 (CH2), 27.6 (CH2), 27.8 (CH2), 36.0 (CH2), 75.8 (CH), 126.4
(2CH), 127.6 (CH), 128.3 (2CH), 140.9 (C), 169.8 (C@O). MS (EI+):
m/z (%) 220 (5) [M+], 164 (28), 117 (100), 91 (55). ½a25D ¼ þ21:2
(c 0.58, CHCl3), ee 95%.
4.4.12. (R)-4-Phenylhept-6-en-3-one, (R)-15a
Yellow pale oil. IR (KBr): m 3415, 3054, 2983, 1712, 1614,
1494 cm1. 1H NMR (CDCl3, 300.13 MHz): d 1.00 (t, 3JHH = 7.3 Hz,
3H), 2.35–2.53 (m, 3H), 2.80–2.90 (m, 1H), 3.76 (t, 3JHH = 7.5 Hz,
1H), 4.97–5.09 (m, 2H), 5.64–5.78 (m, 1H), 7.23–7.30 (m, 5H). 13C
NMR (CDCl3, 75.5 MHz): d 7.7 (CH3), 35.1 (CH2), 36.4 (CH2), 58.4
(CH), 116.5 (CH2), 127.2 (CH), 128.2 (2CH), 128.8 (2CH), 135.8
(CH), 138.6 (C), 210.3 (C@O). MS (APCI+): m/z (%) 189 (100)
[M+H+], 227 (8) [M+K]+. ½a25D ¼ 7:2 (c 0.85, CHCl3), ee 38%.
4.4.13. (S)-4-Phenylbut-1-enyl propionate, (S)-15b
Yellow pale oil. IR (KBr): m 3425, 3053, 2984, 1736, 1642,
1494 cm1. 1H NMR (CDCl3, 300.13 MHz): d 1.18 (t, 3JHH = 7.5 Hz,
3H), 2.36–2.45 (m, 2H), 2.56–2.75 (m, 2H), 5.08–5.15 (m, 2H),
5.65–5.74 (m, 1H), 5.77–5.91 (m, 1H), 7.25–7.43 (m, 5H). 13C–
NMR (CDCl3, 75.5 MHz): d 9.3 (CH3), 28.1 (CH2), 41.1 (CH2), 75.1
(CH), 118.2 (CH2), 126.7 (2CH), 128.1 (CH), 128.6 (2CH), 133.6
(CH), 140.5 (C), 173.9 (C@O). MS (APCI+): m/z (%) 227 (17)
[M+Na+]. ½a25D ¼ þ16:9 (c 0.65, CHCl3), ee 77%.
4.5. Determination of the kinetic parameters
For the determination of the steady-kinetic parameters of wt
PAMO, M446G PAMO and HAPMO with ketones (±)-1–10a, the
enzymatic activity was determined by monitoring NADPH con-
sumption at 340 nm (e340 = 6.22 mM1 cm1). Stocks solutions of
substrates (1.0 M) were made in dimethyl sulfoxide. A reaction
mixture (1.0 mL) usually contained 50 mM Tris/HCl (pH 7.5),
100 lM NADPH, 1% (v/v) DMSO and 0.05 lM BVMO. The presence
of 1% DMSO resulted in only a slight decrease in BVMO activity,
while a higher solubility of certain compounds can be achieved.
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